Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 11, 2021 at 11:50 pm
Share
Kim Forest Enterprise Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 246.669 million compared to TWD 118.180 million a year ago. Operating income was TWD 43.907 million compared to operating loss of TWD 25.792 million a year ago. Net income was TWD 34.832 million compared to net loss of TWD 21.113 million a year ago. Basic earnings per share was TWD 1.18 compared to basic loss per share of TWD 0.89 a year ago. Diluted earnings per share was TWD 1.16 compared to diluted loss per share of TWD 0.89 a year ago.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
KIM FOREST ENTERPRISE CO., LTD. 
